AzTrials
AzTrials

Athletic PerformanceNCT07274566

The Effects of an 8-Week Exer-Genie-Assisted Speed and ABC Drill Training Program on Speed, Hamstring Strength, and Vertical Jump Performance in Female Football Players

A study testing Exer-Genie® Training Protocol in people with Athletic Performance and Muscle Strength, run by Istanbul Rumeli University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the effects of an eight-week Exer-Genie®-assisted speed and agility-balance-coordination (ABC drill) training program on sprint performance, hamstring muscle strength, and vertical jump ability in young female football players. Read more about this study

Who is it for?
Ages 11 to 17 years, women onlyHealthy volunteers can take part
What is being tested?
Exer-Genie® Training Protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Apr 2025to 1 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 17 years
  • Women only
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Female gender.
  • Licensed football players competing in the Turkish Women's Second League.
  • Regularly engaged in football training for at least two years.
  • Aged between 11 and 17 years.

Who cannot join

  • History of recent musculoskeletal injury.
  • Any chronic health condition that could affect athletic performance.
  • Irregular attendance to the training sessions during the study period.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Gedik University, Faculty of Sport Sciences, Indoor Sports Hall

    Istanbul

Other trials in Turkey (Türkiye)

About this study

This study aims to examine the effects of an eight-week Exer-Genie®-assisted speed and agility-balance-coordination (ABC drill) training program on sprint performance, hamstring muscle strength, and vertical jump ability in young female football players. A total of 37 licensed female football players competing in the Turkish Women's Second League participated in the study. Participants were randomly assigned to an experimental group (n = 20) or a control group (n = 17). The study evaluates whether this integrated training approach enhances acceleration, force production, and neuromuscular control compared to regular team training alone.

Read the detailed description

Study Design and Participants The study involves 37 female football players from the Pendik Güven Women's Football Team (mean age 14.4 ± 1.4 years), licensed by the Turkish Football Federation. Participants were randomly assigned to an experimental group (n = 20) or a control group (n = 17).

Intervention Protocol The experimental group completed an Exer-Genie®-assisted sprint and ABC drill training program twice per week for eight weeks (total of 16 sessions). Each session was performed after a standardized warm-up and consisted of six 30-m sprint runs and technical drills. The sprints were performed with resistance applied using the 60-m Exer-Genie® device, with resistance intensity set at 10% of each athlete's body weight. The control group continued with their regular team training only.Outcome Measures 1. Sprint Performance: Assessed via 0-10 m, 10-30 m, and 30 m sprint times using the SmartSpeed electronic timing gate system. 2. Hamstring Strength: Assessed using the NordBord Hamstring Testing System. Specifically, the ISO Prone (0°) protocol was used to measure isometric hamstring strength and impulse values. 3. Vertical Jump: Assessed via the Countermovement Jump (CMJ) test using the ForceDecks system to evaluate lower-limb explosive performance.Statistical Analysis Data were analyzed using repeated-measures ANOVA to evaluate time, group, and interaction effects, with a significance level set at p < 0.05.

Being tested
Exer-Genie® Training Protocol
Keywords
Resistance Training, Athletic Performance, Football

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exer-Genie® Training ProtocolOther

    The protocol consisted of six 30-m sprint runs performed with resistance applied using the 60-m Exer-Genie® device. Resistance was set at 10% of the athlete's body weight. The training was conducted twice a week for 8 weeks.

Study groups in NCT07274566
Study groupRoleWhat they receive
Experimental GroupExperimentalParticipants in this group performed an Exer-Genie®-assisted sprint and agility-balance-coordination (ABC drill) training program twice per week for eight weeks in addition to their warm-up routine.
Receives: Other: Exer-Genie® Training Protocol
Control GroupNo interventionParticipants in this group continued with their regular team football training only and did not receive the Exer-Genie® resistance training.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sprint Performance (30m Sprint Test)

    Sprint performance was evaluated using the SmartSpeed electronic timing gate system. Time was recorded in seconds for 0-10 m (acceleration), 10-30 m (transition), and full 30 m distances. Lower time indicates better performance.

    Measured: Baseline (Pre-test) and immediately after the 8-week intervention (Post-test)

  2. Hamstring Muscle Strength (NordBord ISO Prone)

    Isometric hamstring strength and impulse (force-time curve area) were assessed using the NordBord Hamstring Testing System with the ISO Prone protocol (0 degrees knee extension). Measured in Newtons (N) and N.s.

    Measured: Baseline (Pre-test) and immediately after the 8-week intervention (Post-test)

  3. Vertical Jump Height (Countermovement Jump)

    Lower-limb explosive power was assessed via the Countermovement Jump (CMJ) test using ForceDecks force platforms. Jump height was recorded in centimeters (cm).

    Measured: Baseline (Pre-test) and immediately after the 8-week intervention (Post-test)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2025
  2. Study start10 Apr 2025
  3. Primary completion10 Jun 2025
  4. Study completion1 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
"Participants are randomly assigned to either the experimental group (Exer-Genie training) or the control group (standard training)."
Masking
None (open label)
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07274566
Sponsor's protocol ID
EXERGENIE-FOOTBALL-2025
Status last verified
Nov 2025
First submitted
28 Nov 2025
Last updated
10 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: "The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request."

Publications

  • Keskin Y, Taskiran MY, Elci G. The effects of an 8-week Exer-Genie-assisted speed and ABC drill training program on speed, hamstring strength, and vertical jump performance in female football players. BMC Sports Sci Med Rehabil. 2026 May 13;18(1):311. doi: 10.1186/s13102-026-01744-3.

    PubMed 42129903

Questions about this trial

What is this clinical trial studying?

A study testing Exer-Genie® Training Protocol in people with Athletic Performance and Muscle Strength, run by Istanbul Rumeli University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sprint Performance (30m Sprint Test) (time frame: Baseline (Pre-test) and immediately after the 8-week intervention (Post-test)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07274566, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in